000289950 001__ 289950
000289950 005__ 20240722110957.0
000289950 0247_ $$2doi$$a10.1001/jamaoncol.2024.0827
000289950 0247_ $$2pmid$$apmid:38696176
000289950 0247_ $$2ISSN$$a2374-2437
000289950 0247_ $$2ISSN$$a2374-2445
000289950 0247_ $$2altmetric$$aaltmetric:163050271
000289950 037__ $$aDKFZ-2024-00932
000289950 041__ $$aEnglish
000289950 082__ $$a610
000289950 1001_ $$0P:(DE-He78)59bc83ea3f8c2a5ef6118233f87b5e68$$aLiang, Qunfeng$$b0$$eFirst author$$udkfz
000289950 245__ $$aLonger Interval Between First Colonoscopy With Negative Findings for Colorectal Cancer and Repeat Colonoscopy.
000289950 260__ $$aChicago, Ill.$$bAmerican Medical Association$$c2024
000289950 3367_ $$2DRIVER$$aarticle
000289950 3367_ $$2DataCite$$aOutput Types/Journal article
000289950 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1721639362_2265
000289950 3367_ $$2BibTeX$$aARTICLE
000289950 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000289950 3367_ $$00$$2EndNote$$aJournal Article
000289950 500__ $$a#EA:C120#LA:C120# / 2024 Jul 1;10(7):866-873
000289950 520__ $$aFor individuals without a family history of colorectal cancer (CRC), colonoscopy screening every 10 years is recommended to reduce CRC incidence and mortality. However, debate exists about whether and for how long this 10-year interval could be safely expanded.To assess how many years after a first colonoscopy with findings negative for CRC a second colonoscopy can be performed.This cohort study leveraged Swedish nationwide register-based data to examine CRC diagnoses and CRC-specific mortality among individuals without a family history of CRC. The exposed group included individuals who had a first colonoscopy with findings negative for CRC at age 45 to 69 years between 1990 and 2016. The control group included individuals matched by sex, birth year, and baseline age (ie, the age of their matched exposed individual when the exposed individual's first colonoscopy with findings negative for CRC was performed). Individuals in the control group either did not have a colonoscopy during the follow-up or underwent colonoscopy that resulted in a CRC diagnosis. Up to 18 controls were matched with each exposed individual. Individuals were followed up from 1990 to 2018, and data were analyzed from November 2022 to November 2023.A first colonoscopy with findings negative for CRC, defined as a first colonoscopy without a diagnosis of colorectal polyp, adenoma, carcinoma in situ, or CRC before or within 6 months after screening.The primary outcomes were CRC diagnosis and CRC-specific death. The 10-year standardized incidence ratio and standardized mortality ratio were calculated to compare risks of CRC and CRC-specific death in the exposed and control groups based on different follow-up screening intervals.The sample included 110 074 individuals (65 147 females [59.2%]) in the exposed group and 1 981 332 (1 172 646 females [59.2%]) in the control group. The median (IQR) age for individuals in both groups was 59 (52-64) years. During up to 29 years of follow-up of individuals with a first colonoscopy with findings negative for CRC, 484 incident CRCs and 112 CRC-specific deaths occurred. After a first colonoscopy with findings negative for CRC, the risks of CRC and CRC-specific death in the exposed group were significantly lower than those in their matched controls for 15 years. At 15 years after a first colonoscopy with findings negative for CRC, the 10-year standardized incidence ratio was 0.72 (95% CI, 0.54-0.94) and the 10-year standardized mortality ratio was 0.55 (95% CI, 0.29-0.94). In other words, the 10-year cumulative risk of CRC in year 15 in the exposed group was 72% that of the 10-year cumulative risk of CRC in the control group. Extending the colonoscopy screening interval from 10 to 15 years in individuals with a first colonoscopy with findings negative for CRC could miss the early detection of only 2 CRC cases and the prevention of 1 CRC-specific death per 1000 individuals, while potentially avoiding 1000 colonoscopies.This cohort study found that for the population without a family history of CRC, the 10-year interval between colonoscopy screenings for individuals with a first colonoscopy with findings negative for CRC could potentially be extended to 15 years. A longer interval between colonoscopy screenings could be beneficial in avoiding unnecessary invasive examinations.
000289950 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000289950 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000289950 7001_ $$0P:(DE-He78)ef3f7c40c2c68936a43baab29d559371$$aMukama, Trasias$$b1
000289950 7001_ $$aSundquist, Kristina$$b2
000289950 7001_ $$aSundquist, Jan$$b3
000289950 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b4$$udkfz
000289950 7001_ $$0P:(DE-He78)e56510c7dedbff7a279ad76dad80eeda$$aKharazmi, Elhamalsadat$$b5
000289950 7001_ $$0P:(DE-He78)b510b884502b619724039bf33fdae68a$$aFallah, Mahdi$$b6$$eLast author$$udkfz
000289950 773__ $$0PERI:(DE-600)2810928-4$$a10.1001/jamaoncol.2024.0827$$n7$$p866-873$$tJAMA oncology$$v10$$x2374-2437$$y2024
000289950 909CO $$ooai:inrepo02.dkfz.de:289950$$pVDB
000289950 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)59bc83ea3f8c2a5ef6118233f87b5e68$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000289950 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ef3f7c40c2c68936a43baab29d559371$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000289950 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000289950 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e56510c7dedbff7a279ad76dad80eeda$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000289950 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b510b884502b619724039bf33fdae68a$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000289950 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000289950 9141_ $$y2024
000289950 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJAMA ONCOL : 2022$$d2023-08-24
000289950 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-24
000289950 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-24
000289950 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-24
000289950 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-08-24
000289950 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-24
000289950 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-08-24
000289950 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-08-24
000289950 915__ $$0StatID:(DE-HGF)9925$$2StatID$$aIF >= 25$$bJAMA ONCOL : 2022$$d2023-08-24
000289950 9202_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x0
000289950 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x0
000289950 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x1
000289950 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000289950 9200_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x0
000289950 980__ $$ajournal
000289950 980__ $$aVDB
000289950 980__ $$aI:(DE-He78)C120-20160331
000289950 980__ $$aI:(DE-He78)C070-20160331
000289950 980__ $$aI:(DE-He78)HD01-20160331
000289950 980__ $$aUNRESTRICTED